Brief: HLS Therapeutics Announces Second Quarter Fiscal 2021 Financial Results
05/08/2021 13:29
Aug 5 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS ANNOUNCES SECOND QUARTER FISCAL 2021
FINANCIAL
RESULTS
* Q2 REVENUE $14.9 MILLION VERSUS $12.6 MILLION
* Q2 LOSS PER SHARE $0.07
Source text for Eikon: ID:nCNWyRjSla
Further company coverage: HLS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group